HYDROCORTISONE CREA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Contract SPE2DP22F1423 is a commercial items award issued by the Defense Logistics Agency under delivery order SPE2DX15D9383 to DMS Pharmaceutical Group Inc. The contract, which was posted on August 25, 2026, established a total award amount of 4,999,999.00 dollars and incorporated standard FAR 52.212 clauses regarding delivery, payment, and defense priority and allocation requirements. The specific line item associated with this award was for Hydrocortisone Crea, identified by NSN 6505009262095. However, modification P00001 subsequently resulted in the total cancellation of CLIN 0001 for 20 units. This termination for the government's convenience was executed due to the decommissioning of ships and the presence of aged orders, reducing the value of that specific order from 122.40 dollars to zero.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
